Tag: cytokine storm
No posts to display
News
Ochre Bio and Boehringer Ingelheim to develop novel regenerative treatments for patients with advanced...
Ochre Bio has formed a partnership with Boehringer Ingelheim focused on the discovery and development of novel, first-in-class regenerative treatments for chronic liver diseases (CLDs),...
U.S. FDA approves subcutaneous administration of Takeda’s ENTYVIO for Crohn’s disease
The U.S. Food and Drug Administration (FDA) has approved Takeda's ENTYVIO (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely...
CARVYKTI becomes first BCMA-targeted treatment approved by European Commission for patients with relapsed and...
The European Commission (EC) has approved a Type II variation for Janssen-Cilag International NV's (a Johnson & Johnson company) CARVYKTI (ciltacabtagene autoleucel; cilta-cel).
This latest...
